First Midwest Bank Trust Division’s Iovance Biotherapeutics IOVA Stock Holding History

First Midwest Bank Trust Division’s Portfolio IOVA Stock Details IOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$452K	Sell	23,659 -111,417	-82%	-$2.45M	0.06%	279
2021 Q3	$3.33M	Sell	135,076 -34,984	-21%	-$824K	0.47%	50
2021 Q2	$4.42M	Buy	170,060 +143,460	+539%	+$3.73M	0.6%	39
2021 Q1	$842K	Buy	26,600 +10,806	+68%	+$448K	0.12%	184
2020 Q4	$733K	Sell	15,794 -64,241	-80%	-$2.55M	0.11%	190
2020 Q3	$2.63M	Buy	80,035 +22,551	+39%	+$691K	0.41%	64
2020 Q2	$1.58M	Buy	57,484 +9,958	+21%	+$327K	0.26%	99
2020 Q1	$1.42M	Buy	+47,526	New	+$1.26M	0.26%	93
2019 Q2	–	Sell	-59,876	Closed	-$569K	–	383
2019 Q1	$569K	Buy	+59,876	New	+$582K	0.08%	254

Other funds holding IOVA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Midwest Bank Trust Division's IOVA Position: Q4 2021 in Review

First Midwest Bank Trust Division reduced its Iovance Biotherapeutics (IOVA) stake by 82% in Q4 2021, selling an estimated $2.45M and leaving 23,659 shares worth $452K. The position accounts for 0.06% of the portfolio, ranked #279.

First Midwest Bank Trust Division first reported a position in IOVA in Q1 2019 and has held it in 9 quarters since. The position peaked at $4.42M in Q2 2021. 246 funds tracked by Wall St. Rank hold IOVA as of Q4 2021.

First Midwest Bank Trust Division held 23,659 shares of Iovance Biotherapeutics worth $452K as of Q4 2021.
First Midwest Bank Trust Division sold 111,417 Iovance Biotherapeutics shares in Q4 2021, an estimated $2.45M.
Iovance Biotherapeutics made up 0.06% of First Midwest Bank Trust Division's portfolio in Q4 2021, its #279 holding.
First Midwest Bank Trust Division first reported a position in Iovance Biotherapeutics in Q1 2019 and has held it in 9 quarters since.
First Midwest Bank Trust Division's Iovance Biotherapeutics position peaked at $4.42M in Q2 2021.
246 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q4 2021.

Based on First Midwest Bank Trust Division's 13F filing for Q4 2021, filed 18 Jan 2022.